NO20000262L - Plasmider, deres konstruksjon og deres anvendelse i fremstillingen av interleukin-4 og interleukin-4-mutanter - Google Patents

Plasmider, deres konstruksjon og deres anvendelse i fremstillingen av interleukin-4 og interleukin-4-mutanter

Info

Publication number
NO20000262L
NO20000262L NO20000262A NO20000262A NO20000262L NO 20000262 L NO20000262 L NO 20000262L NO 20000262 A NO20000262 A NO 20000262A NO 20000262 A NO20000262 A NO 20000262A NO 20000262 L NO20000262 L NO 20000262L
Authority
NO
Norway
Prior art keywords
interleukin
construction
plasmids
mutants
preparation
Prior art date
Application number
NO20000262A
Other languages
English (en)
Other versions
NO20000262D0 (no
NO327317B1 (no
Inventor
Heiner Apeler
Hermann Wehlmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20000262D0 publication Critical patent/NO20000262D0/no
Publication of NO20000262L publication Critical patent/NO20000262L/no
Publication of NO327317B1 publication Critical patent/NO327317B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
NO20000262A 1999-01-20 2000-01-19 Vektor for fremstillingen av IL-4 og IL-4-mutanter, DNA-konstruksjon og E.coli. NO327317B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99100967A EP1022339B1 (en) 1999-01-20 1999-01-20 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins

Publications (3)

Publication Number Publication Date
NO20000262D0 NO20000262D0 (no) 2000-01-19
NO20000262L true NO20000262L (no) 2000-07-21
NO327317B1 NO327317B1 (no) 2009-06-08

Family

ID=8237378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000262A NO327317B1 (no) 1999-01-20 2000-01-19 Vektor for fremstillingen av IL-4 og IL-4-mutanter, DNA-konstruksjon og E.coli.

Country Status (15)

Country Link
US (1) US6506590B1 (no)
EP (1) EP1022339B1 (no)
JP (2) JP2000210091A (no)
KR (1) KR100665148B1 (no)
AT (1) ATE334202T1 (no)
AU (1) AU772897B2 (no)
CA (1) CA2294575C (no)
CZ (1) CZ294279B6 (no)
DE (1) DE69929638T2 (no)
DK (1) DK1022337T3 (no)
ES (1) ES2269027T3 (no)
HU (1) HU224491B1 (no)
NO (1) NO327317B1 (no)
PT (1) PT1022337E (no)
SK (1) SK285603B6 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10022258A1 (de) 2000-05-08 2001-11-15 Bayer Ag Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration
KR100443570B1 (ko) * 2001-07-31 2004-08-09 크레아젠 주식회사 재조합 인간 인터루킨-4의 제조방법
EP1314739A1 (en) 2001-11-22 2003-05-28 Bayer Ag Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
JP2006055082A (ja) * 2004-08-20 2006-03-02 National Institute Of Advanced Industrial & Technology 発光甲虫由来赤色発光酵素安定体の生産及び精製法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689406A (en) * 1983-08-10 1987-08-25 Amgen Enhancement of microbial expression of polypeptides
AU597951B2 (en) * 1986-03-27 1990-06-14 Monsanto Company Enhanced protein production in bacteria by employing a novel ribosome binding site
ATE123526T1 (de) * 1987-08-17 1995-06-15 Hoffmann La Roche Hochreprimierbare expressionskontrollsequenzen.
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees
MY124565A (en) * 1996-07-19 2006-06-30 Bayer Corp High-affinity interleukin-4-muteins

Also Published As

Publication number Publication date
HU224491B1 (hu) 2005-09-28
DK1022337T3 (da) 2006-11-06
AU772897B2 (en) 2004-05-13
ATE334202T1 (de) 2006-08-15
DE69929638T2 (de) 2006-09-21
CA2294575C (en) 2009-04-07
SK762000A3 (en) 2000-08-14
HU0000185D0 (en) 2000-04-28
EP1022339B1 (en) 2006-02-01
PT1022337E (pt) 2006-11-30
HUP0000185A2 (en) 2002-09-28
KR20000053523A (ko) 2000-08-25
NO20000262D0 (no) 2000-01-19
KR100665148B1 (ko) 2007-01-09
DE69929638D1 (de) 2006-04-13
CZ2000214A3 (cs) 2000-08-16
NO327317B1 (no) 2009-06-08
JP2000210091A (ja) 2000-08-02
CA2294575A1 (en) 2000-07-20
CZ294279B6 (cs) 2004-11-10
EP1022339A1 (en) 2000-07-26
ES2269027T3 (es) 2007-04-01
US6506590B1 (en) 2003-01-14
AU1250700A (en) 2000-07-27
JP2010284174A (ja) 2010-12-24
SK285603B6 (sk) 2007-04-05

Similar Documents

Publication Publication Date Title
HK1046016A1 (en) Recombinant gelatin in vaccines
DK1021547T3 (da) Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
DK0409113T3 (da) Muteiner af humant erythropoietin, deres fremstilling og anvendelse
DK371389A (da) Substituerede aminomethyltetraliner og deres heterocycliske analoge, deres fremstilling og anvendelse
DE60142508D1 (de) Menschliche aminoacyl-trna synthetase polypeptide zur regulation der angiogenese
DK1317537T3 (da) Sammensætninger og fremgangsmåder med G-CSF analoger
DE69708121D1 (de) Halogenid-enthaltende insulinzubereitungen
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
NO983946L (no) Parapoxviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner
NZ506422A (en) Therapeutic uses of keratinocyte growth factor -2
NO308030B1 (no) Kolkisinderivater og deres terapeutiske anvendelse
NO20000262L (no) Plasmider, deres konstruksjon og deres anvendelse i fremstillingen av interleukin-4 og interleukin-4-mutanter
NO20001934L (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
DE69312319T2 (de) Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
DK575787D0 (da) Rekombinant hcmv-afledt plasmid, dets fremstilling og anvendelse
EP1022337A3 (en) Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
DE60216321D1 (de) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazinoä4,5-büindol-1-karboxamid-derivate, ihre herstellung und therapeutische verwendung
WO2000027881A3 (de) Menschliche interleukin -10 mutantenproteine
DE3788888D1 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
ATE412051T1 (de) Klonierung und rekombinante herstellung des crf- rezeptors (corticotropin auslösefaktor)
DE60044468D1 (de) Herstellung von sekretierten polypeptiden
NO993546L (no) 1,4-dihydropyridinderivater og deres anvendelse i terapi
TR200000916T2 (tr) İkameli piperidin türevleri.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees